首页 > 技术支持 > 文献速递

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models

Nature Immunology
https://doi.org/10.1038/s41590-026-02545-z

Related products

Catalog No. Product Name Description Target
JN009013 Anti-Mycobacterium tuberculosis esxA/ESAT-6 Recombinant Antibody (SAA2172) 6 kDa early secretory antigenic target, ESAT-6, esxA, esaT6, Rv3875, MTV027.10